Inovio Pharmaceuticals, Inc.
NASDAQ: INO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jacqueline E. Shea
- Employees
- 134
- Headquarters
- Plymouth Meeting, United States
- IPO year
- 1998
- Market cap
- $58.9M
- Website
- https://www.inovio.com
Loading INO…
Loading profile data…Frequently asked questions about INO
What does Inovio Pharmaceuticals, Inc. (INO) do?
Inovio Pharmaceuticals, Inc. is a biotechnology firm dedicated to the research, development, and market introduction of DNA-based treatments. Its core mission is to prevent and cure illnesses associated with human papillomavirus (HPV), various types of cancer, and infectious diseases. The company's advanced DNA medicine platform utilizes meticul...
Where does INO trade?
Inovio Pharmaceuticals, Inc. (INO) trades on the NASDAQ Global Select.
What sector is INO in?
Inovio Pharmaceuticals, Inc. (INO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Inovio Pharmaceuticals, Inc.?
Jacqueline E. Shea is the chief executive officer of Inovio Pharmaceuticals, Inc. (INO).
Where is Inovio Pharmaceuticals, Inc. headquartered?
Inovio Pharmaceuticals, Inc. is headquartered in United States.
Does INO pay a dividend?
Inovio Pharmaceuticals, Inc. (INO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did INO go public?
Inovio Pharmaceuticals, Inc. (INO) completed its initial public offering in 1998.